This program will address various legal, regulatory, and policy hurdles for health care businesses that venture into social media advertising and marketing, including relationships between health care providers and social media influencers. Nixon Peabody’s national health care and entertainment team will address key issues facing innovative digital health companies and traditional health care providers when engaging in online and social media marketing.
Our discussion will cover:
• fraud and abuse restrictions on referrals, including the federal Anti-Kickback Statute and the Stark Law;
• truth-in-advertising laws, including guidance from the Federal Trade Commission;
• state laws impacting advertising of physician services;
• evolving policies from social media companies, including Facebook’s recent changes to its policies around prescription drug advertising for online pharmacies, telehealth providers, and pharmaceutical manufacturers; and
• key considerations for content creators and influencers using these platforms to market health care services and products.
During this course, we will go over your rights under the Freedom of Information Act (FOIA) and Priv...
Trial Starts Now: Winning the Final Six Months provides a comprehensive guide to the critical tasks ...
In Part 2, Mr. Kornblum will again use segments from the movies to teach pre-trial and trial tactics...
Objections are among the most powerful — and most misunderstood — tools in a trial lawye...
AI agents — autonomous systems capable of planning, deciding, and acting independently across ...
Open-source AI models have gone from niche developer tools to enterprise essentials almost overnight...
This dynamic CLE presentation challenges trial lawyers to rethink everything they were taught about ...
Modern mediation increasingly brings together parties, counsel, and neutrals across a broad range of...
This course on trade secrets litigation provides real-world best practices through all key stages of...
Class action litigation continues to evolve rapidly in response to an innovative plaintiffs’ b...